Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
Amlodipine besylate 6.944mg equivalent to amlodipine; Olmesartan medoxomil
PFIZER PRIVATE LIMITED
C09DB02
5mg
TABLET, FILM COATED
Amlodipine besylate 6.944mg equivalent to amlodipine 5mg; Olmesartan medoxomil 40mg
ORAL
Prescription Only
Daiichi Sankyo Europe GmbH
ACTIVE
2011-06-06
1 NAME OF THE MEDICINAL PRODUCT Azoren 20 mg/5 mg film-coated tablets. Azoren 40 mg/5 mg film-coated tablets. Azoren 40 mg/10 mg film-coated tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Azoren 20 mg/5 mg film-coated tablets: Each film-coated tablet of Azoren contains 20 mg of olmesartan medoxomil and 5 mg of amlodipine (as amlodipine besylate). Azoren 40 mg/5 mg film-coated tablets: Each film-coated tablet of Azoren contains 40 mg of olmesartan medoxomil and 5 mg of amlodipine (as amlodipine besylate). Azoren 40 mg/10 mg film-coated tablets: Each film-coated tablet of Azoren contains 40 mg of olmesartan medoxomil and 10 mg of amlodipine (as amlodipine besylate). For a full list of excipients (see section 6.1). 3 PHARMACEUTICAL FORM Film-coated tablet. Azoren 20 mg/5 mg film-coated tablets: White, round, film-coated tablet with C73 debossed on one side. Azoren 40 mg/5 mg film-coated tablets: Cream, round, film-coated tablet with C75 debossed on one side. Azoren 40 mg/10 mg film-coated tablets: Brownish-red, round, film-coated tablet with C77 debossed on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of essential hypertension. Azoren is indicated in patients whose blood pressure is not adequately controlled on olmesartan medoxomil or amlodipine monotherapy (see sections 4.2 and 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults _ The recommended dosage of Azoren is 1 tablet per day. Azoren 20 mg/5 mg may be administered in patients whose blood pressure is not adequately controlled by 20 mg olmesartan medoxomil or 5 mg amlodipine alone. Azoren 40 mg/5 mg may be administered in patients whose blood pressure is not adequately controlled by Azoren 20 mg/5 mg. Azoren 40 mg/10 mg may be administered in patien Read the complete document
1 NAME OF THE MEDICINAL PRODUCT Azoren 20 mg/5 mg film-coated tablets. Azoren 40 mg/5 mg film-coated tablets. Azoren 40 mg/10 mg film-coated tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Azoren 20 mg/5 mg film-coated tablets: Each film-coated tablet of Azoren contains 20 mg of olmesartan medoxomil and 5 mg of amlodipine (as amlodipine besylate). Azoren 40 mg/5 mg film-coated tablets: Each film-coated tablet of Azoren contains 40 mg of olmesartan medoxomil and 5 mg of amlodipine (as amlodipine besylate). Azoren 40 mg/10 mg film-coated tablets: Each film-coated tablet of Azoren contains 40 mg of olmesartan medoxomil and 10 mg of amlodipine (as amlodipine besylate). For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. Azoren 20 mg/5 mg film-coated tablets: White, round, film-coated tablet with C73 debossed on one side. Azoren 40 mg/5 mg film-coated tablets: Cream, round, film-coated tablet with C75 debossed on one side. Azoren 40 mg/10 mg film-coated tablets: Brownish-red, round, film-coated tablet with C77 debossed on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of essential hypertension. Azoren is indicated in patients whose blood pressure is not adequately controlled on olmesartan medoxomil or amlodipine monotherapy (see sections 4.2 and 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults_ The recommended dosage of Azoren is 1 tablet per day. Azoren 20 mg/5 mg may be administered in patients whose blood pressure is not adequately controlled by 20 mg olmesartan medoxomil or 5 mg amlodipine alone. Azoren 40 mg/5 mg may be administered in patients whose blood pressure is not adequately controlled by Azoren 20 mg/5 mg. Azoren 40 mg/10 mg may be administered in patients whose blood pressure is not adequately controlled by Azoren 40 mg/5 mg. A step-wise titration of the dosage of the individual components is recommended before changing to the fixed combination. When clinically appropriate, direct change from monotherapy to the fixed combination ma Read the complete document